from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2878c/mpt53

LFCtreatmentdescriptionclass of inhibitor

0.481

Amikacinug/mL Amikacintranslation

1.440

Cap5-10ug/mL Capreomycintranslation

3.051

Rox10-50 ug/mL Roxithromycintranslation

-0.322

SM2-5 ug/mL Streptomycintranslation

1.751

Tet5-10 ug/mL Tetracyclinetranslation

-1.208

Rif0.2-5ug/mL Rifampicintranscription

0.212

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.186

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.294

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.223

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.452

Clofazimine10-13 ug/mL Clofaziminerespiration

-1.117

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.440

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.948

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.384

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.590

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.349

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.127

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.191

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.580

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.970

KCN5-20 ug/mL Potassium cyaniderespiration

-0.489

NaN30.2-2 mM Sodium aziderespiration

0.652

Nigericin50 uM Nigericinrespiration

0.195

TRC10-150 ug/mL Triclosanrespiration

0.593

TRZ10-25 ug/mL Thioridazinerespiration

3.066

Valinomycin0.5-10 uM Valinomycinrespiration

-0.470

ZnSO42 mM ZnSO4respiration

0.161

menadione6-10 ug/mL Menadionerespiration

0.037

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.688

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.419

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.802

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.959

NRP_1Non-replicating persistence stage 1dosRassociated

-0.700

Amp0.2mg/mL AmpicillincellWall

-0.245

Cephalexin20-100 ug/mL CephalexincellWall

-0.744

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.892

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.972

EMB10-20 ug/mL EthambutolcellWall

-0.694

Eta12-40 ug/mL EthionamidecellWall

-0.750

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.273

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.754

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.271

BZA0.12 mg/mL BenzamidearomaticAmides

-0.237

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.293

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.586

H2O24 mM hydrogen peroxideDNAdamaging

-0.390

Levo10 ug/mL LevofloxacinDNAdamaging

0.082

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.189

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.535

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.128

UVUV-irradiationDNAdamaging

1.473

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.443

Antimycin12.5-50 ug/mL Antimycin A?

1.421

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.195

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.189

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.067

PA8240.2-2 ug/mL PA-824?

0.256

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.285

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.215

Verapamil50 uM Verapamil?

0.226

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.402

methoxatin10-20 ug/mL Methoxatin?